Cargando…
Dual antiplatelet therapy may increase the risk of non-intracranial haemorrhage in patients with minor strokes: a subgroup analysis of the CHANCE trial
AIM: The aim of this study was to explore the difference between haemorrhagic events among those patients on either aspirin or aspirin plus clopidogrel who were enrolled in the Clopidogrel in High-Risk Patients with Acute Non-disabling Ischemic Cerebrovascular Events (CHANCE) trial. METHODS: This wa...
Autores principales: | Wang, David, Gui, Li, Dong, Yi, Li, Hao, Li, Shujuan, Zheng, Huaguang, Wang, Anxin, Meng, Xia, Liu, Li-Ping, Wang, Yi-Long, Wang, Guangyao, Jing, Jing, Li, Zixiao, Zhao, Xing-Quan, Wang, Yong-Jun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5435197/ https://www.ncbi.nlm.nih.gov/pubmed/28959461 http://dx.doi.org/10.1136/svn-2016-000008 |
Ejemplares similares
-
Association of elevated hs-CRP and multiple infarctions with outcomes of minor stroke or TIA: subgroup analysis of CHANCE randomised clinical trial
por: Wang, Guangyao, et al.
Publicado: (2020) -
Risk factors associated with 90-day recurrent stroke in patients on dual antiplatelet therapy for minor stroke or high-risk TIA: a subgroup analysis of the CHANCE trial
por: Wangqin, Runqi, et al.
Publicado: (2017) -
The association of white matter hyperintensities with stroke outcomes and antiplatelet therapy in minor stroke patients
por: Xu, Yu-Yuan, et al.
Publicado: (2020) -
Low LDL-C level and intracranial haemorrhage risk after ischaemic stroke: a prospective cohort study
por: Xu, Jie, et al.
Publicado: (2022) -
Clopidogrel with aspirin in High-risk patients with Acute Non-disabling Cerebrovascular Events II (CHANCE-2): rationale and design of a multicentre randomised trial
por: Wang, Yongjun, et al.
Publicado: (2021)